Thursday, 29 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Financial Results

Panacea Biotec Financial Results

Panacea Biotec approved FY2026 audited financial results and skipped dividends due to losses. The board also appointed Rajinder Singh Manku as an Independent Director.

Source

BSE filing, NSE: PANACEABIO. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Panacea Biotec Ltd: key numbers

Share price
₹329.05
Market cap
₹2,015 Cr
Revenue (annual)
₹639.8 Cr
Net profit (annual)
₹-5.37 Cr
P/E (TTM)
-283.1×Sector 46.1×
Promoter holding
72.48%+0.00% QoQ
FII holding
2.75%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Panacea Biotec Ltd

All →

Other financial results announcements

All →